Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells

INTRODUCTION: An elevated serum PSA is the only biomarker routinely used in screening for prostate cancer to indicate a prostate biopsy. However, it is not specific for prostate cancer and the neutrophil/lymphocyte ratio has been suggested as an alternative. We present a prospective study of men wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Nigel P, Fuentealba, Cynthia, Reyes, Eduardo, López, Marco Antonio, Aníbal, Aníbal, Minzer, Simona, Munoz, Lorena, Orrego, Shenda, Guzman, Eghon, Arzeno, Lucas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062991/
https://www.ncbi.nlm.nih.gov/pubmed/31759363
http://dx.doi.org/10.31557/APJCP.2019.20.11.3385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062991/
https://www.ncbi.nlm.nih.gov/pubmed/31759363
http://dx.doi.org/10.31557/APJCP.2019.20.11.3385

Ejemplares similares